Clinical Trials List
Protocol Number102-0831A
Not yet recruiting
2013-04-01 - 2016-03-31
Others
Terminated1
-
Trial Applicant
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Chih-Liang Wang Division of Hematology & Oncology
- Chih-Teng Yu Division of Hematology & Oncology
- Fu-Tsai Chung Division of Hematology & Oncology
- Cheng-Ta Yang Division of Hematology & Oncology
- Ping-Chih Hsu Division of Hematology & Oncology
- Tzu-Chen Yen Division of Nuclear Medicine
- Po-Hao Feng Division of Hematology & Oncology
- Chien-Ying Liu Division of Hematology & Oncology
- Chih-Hsi Kuo Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
100 participants
-
Global
0 participants
